TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
RLAY

Relay Therapeutics Inc

Healthcare · Biotechnology

17.50$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow RLAY
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – -124.0% -2,456.5% -16,617.7% -1,175.6% -2,489.3% -1,533.4%
– – 4.3% 129.6% 299.1% 20.6% 54.6% -9.1%
– – 38.7% 1,599.7% 4,065.0% 336.8% 940.7% 406.5%
– – 38.2% 1,693.3% 4,065.0% – – –
– – -103.0% 3,213.7% 814.3% -127.1% 146.1% -151.8%
– – 2.3% 114.6% 656.2% 16.2% 20.2% 2.7%
– – 98.8% -15,830.7% -13,667.3% 1,008.5% -410.5% 1,255.6%
– – 519.1% 194.1% 122.1% – 14.8% 7.0%
– – -3.0% – – – – –
– – 516.0% 12,812.5% 20,992.8% 136.0% 2,699.6% 10.4%
– – 490.8% -5,474.6% -9,292.2% -31.0% -200.2% -267.4%
– – -126.3% -2,571.0% -17,273.9% -1,191.7% -2,509.5% -1,536.1%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?